Greece vs Nicaragua: The number of people with susceptibility test result for rifampicin
Greece
45.08
in 2021
Nicaragua
46.72
in 2021
Greece rank
119th
Nicaragua rank
117th
The number of people with susceptibility test result for rifampicin over time
- Greece
- Nicaragua
How they compare
Nicaragua currently reports 46.72 against 45.08 in Greece, a difference of 1.64.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Greece ahead.
Greece ranks 119th and Nicaragua ranks 117th of 146 countries.
Across the 2 decades both report, Greece averaged higher in 1 and Nicaragua in 1.
Head to head by decade
| Decade | Greece | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.64 | 44.17 | 11.47 | Greece |
| 2020s | 69.01 | 71.24 | 2.23 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Nicaragua?
- Nicaragua, at 46.72 against 45.08 in Greece as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Nicaragua?
- 1.64, with Nicaragua ahead.
- How many years of comparable data are there for Greece and Nicaragua?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Nicaragua rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 119th and Nicaragua ranks 117th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.